Organon & Co | OGN - Capital Ordinário





Capital Ordinário Alterar Data
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celltrion KRW 218.78M 1.5M 2025-09
Cspc Pharmaceutical CNY 11.52B 486M 2025-06
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Gilead Sciences USD 1.24B 1000K 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
Kangmei Pharma CNY 13.86B 0 2025-06
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Merck USD 2.49B 15.79M 2025-09
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Novartis USD 1.92B 17.06M 2025-09
Organigram Holdings CAD 134.46M 438.86K 2025-09
Organon & Co USD 259.98M 18K 2025-09
Ovoca Bio EUR 11.06M 0 2022-06
Pharma Mar EUR 17.36M 214.99K 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Sartorius EUR 69.04M 0 2025-09
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tilray USD 1.06B 86.93M 2025-03